香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不會就本公告全 部 或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 香港，二零二五年八月十五日 於 本 公 佈 日 期 ， 執 行 董 事 為 杜 林 東 先 生 ； 非 執 行 董 事 為 劉 曉 東 先 生 及 李 弘 希 女 士 ； 而 獨 立 非 執 行 董 事 為 宗 士 劍 先 生 、 魯 林 先 生 及 劉 小 紅 先 生 。 中國金融國際投資有限公司 CHINA FINANCIAL INTERNATIONAL INVESTMENTS LIMITED （於開曼群島註冊成立並遷冊往百慕達之有限公司） （股份代號：721） 中 國 金 融 國 際 投 資 有 限 公 司 公 佈 於 二 零 二 五 年 七 月三十 一 日 未 經 審 核 之 每 普 通 股 之 綜 合 資 產 淨 值 約 為 港 幣 0.02 元。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 本月底法定/註冊股本總額： HKD 300,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 致：香港交易及結算所有限公司 公司名稱: 中國金融國際投資有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00721 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000,000 | HKD | | 0.01 HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 30,000,000, ...

Group 1 - The core viewpoint of the news highlights the performance of China Financial International, which has seen significant stock price increases recently, outperforming the Hang Seng Index [1][2] - As of July 11, the Hang Seng Index rose by 0.46% to 24,139.57 points, while China Financial International's stock price increased by 13.21% to HKD 0.06 per share, with a trading volume of 18.9 million shares and a turnover of HKD 12.04 million [1] - Over the past month, China Financial International has accumulated a rise of 15.22%, and since the beginning of the year, it has surged by 96.3%, outperforming the Hang Seng Index's increase of 19.78% [2] Group 2 - Financial data shows that as of December 31, 2024, China Financial International achieved total operating revenue of HKD 3.5569 million, a year-on-year increase of 242.03%, while the net profit attributable to shareholders decreased by 97.6% to HKD 1.5196 million [2] - The company's debt-to-asset ratio stands at 13.03% [2] - Currently, there are no institutional investment ratings for China Financial International, and its price-to-earnings ratio is -14.99, ranking 100th in the industry, compared to an average TTM P/E ratio of 6.23 for other financial sectors [2]

Group 1 - The 23rd China International Conference in Finance (CICF) was successfully held in Shenzhen, showcasing its growing influence in the global financial academic community [2] - The conference received 3,056 submissions, with 1,758 valid papers, and ultimately accepted 236 papers, highlighting the high academic standards and international impact of the event [2] - The conference registered 1,345 attendees, marking a new high for in-person participation in a non-virtual year [2] Group 2 - Professor Thomas J. Sargent, a Nobel laureate, delivered a keynote speech on optimal fiscal policy using short-term debt, sharing insights from his latest research [4][5] - The research addresses challenges in implementing optimal fiscal plans when initial government debt is high, proposing a modified timing protocol to ensure successful execution of Ramsey plans [5] - This study offers new perspectives for sustainable fiscal policy design, particularly relevant in the context of rising government debt in major economies [6] Group 3 - The conference agenda spanned three days, featuring 60 academic sub-sessions and 472 presentations covering various cutting-edge topics in finance, including AI in capital markets, ESG issues, and macro-financial dynamics [7] - The event emphasized the importance of academic exchange and international collaboration, with participation from leading scholars and institutions [9] - The Hong Kong University of Science and Technology and other institutions played a significant role in organizing and contributing to the conference, promoting global financial research [9]

Group 1 - The 23rd China International Conference in Finance (CICF) was successfully held in Shenzhen, showcasing its growing influence in the global financial academic community [1][2] - The conference received 3,056 submissions, with 1,758 valid papers and 236 accepted papers, highlighting its significance in the finance and economics field [2] - The event recorded a registration of 1,345 participants, marking a new high for in-person attendance, emphasizing the conference's academic stature and international impact [2] Group 2 - Nobel laureate Thomas J. Sargent delivered a keynote speech on optimal fiscal policy based on short-term debt, providing new insights for sustainable fiscal policy design amid high government debt levels globally [2] - The conference agenda spanned three days, featuring 60 academic sub-sessions and 472 presentations covering various cutting-edge topics in finance, including AI-driven capital markets and asset pricing [3] - The Hong Kong University of Science and Technology and other institutions actively participated in organizing and evaluating papers, contributing to the establishment of a global financial research platform [3]

Group 1 - The Hang Seng Index closed at 23,332.72 points, down 0.05% on May 19 [1] - China Financial International (00721.HK) closed at HKD 0.072 per share, up 166.67%, with a trading volume of 162 million shares and a turnover of HKD 16.66 million, showing a volatility of 1,088.89% [1] - Over the past month, China Financial International has shown a cumulative increase of 0%, underperforming the Hang Seng Index, which has increased by 16.38% year-to-date [1] Group 2 - As of December 31, 2024, China Financial International reported total operating revenue of HKD 3.5569 million, a year-on-year increase of 242.03% [1] - The company reported a net profit attributable to shareholders of HKD 1.5196 million, a year-on-year decrease of 97.6% [1] - The asset-liability ratio stands at 13.03% [1] Group 3 - Currently, there are no institutional investment ratings for China Financial International [2] - The average price-to-earnings (P/E) ratio for the financial industry (TTM) is 21.18 times, with a median of -0.09 times [2] - China Financial International has a P/E ratio of -7.64 times, ranking 113th in the industry [2]

港股中国金融国际股价早盘一度涨近900%，现涨幅回落，涨超300%，成交额307.84万港元。 无需港股通，A股账户就能T+0买港股>> ...

Core Viewpoint - China Financial International (00721.HK) experienced a significant surge in stock price, initially rising nearly 900% before settling at over 300% increase, currently priced at 0.124 HKD with a trading volume of 3.0784 million HKD [1] Group 1 - The stock price of China Financial International saw a peak increase of nearly 900% during early trading [1] - The current trading price is reported at 0.124 HKD, reflecting a more than 300% increase from previous levels [1] - The total trading volume reached 3.0784 million HKD, indicating active market participation [1]

Financial Performance - The company reported unaudited revenue of HKD 164,000 for the six months ending December 31, 2024, compared to HKD 4,123,000 for the same period in 2023, indicating a significant decline[2]. - Other income and losses amounted to HKD 3,677,000, a decrease from HKD 1,000,000 year-on-year[2]. - The company recorded a fair value gain of HKD 1,139,000 from financial assets, down from HKD 72,082,000 in the previous year[2]. - Administrative expenses decreased to HKD 2,780,000 from HKD 4,263,000, reflecting a reduction of approximately 34.8%[2]. - The company reported a pre-tax profit of HKD 1,641,000, significantly lower than HKD 68,325,000 in the prior year[2]. - The net profit for the period was HKD 1,641,000, compared to HKD 68,325,000 in the same period last year, marking a substantial decline[2]. - Total comprehensive income for the period was HKD 1,926,000, down from HKD 79,262,000 year-on-year[4]. - The group recorded a profit of HKD 1,641,000 for the six months ending December 31, 2024[9]. - Basic earnings per share for the six months ending December 31, 2024, were HKD 0.15, compared to HKD 6.23 for the same period in 2023[25]. - The group recorded a pre-tax profit of HKD 1,641,000 for the six months ending December 31, 2024[17]. - The group did not declare an interim dividend for the six months ending December 31, 2024[24]. - The total employee cost for the period was HKD 1,102,000, a decrease from HKD 2,327,000 for the same period in 2023[44]. Assets and Liabilities - The company's total assets less current liabilities stood at HKD 167,123,000, an increase from HKD 165,514,000[5]. - Cash and cash equivalents increased to HKD 38,303,000 from HKD 19,000, indicating improved liquidity[5]. - The company’s net current assets amounted to HKD 101,652,000, up from HKD 100,132,000, showing a slight improvement in financial health[5]. - The net asset value of the group increased to HKD 167,069,000 as of December 31, 2024, compared to HKD 165,143,000 as of June 30, 2024[6]. - The group's total equity remained stable at HKD 167,069,000, with a net asset value per share of HKD 1.52[6]. - The group’s total liabilities were not allocated to reportable segments, indicating a focus on asset management[19]. - The group had no bank borrowings or capital commitments as of December 31, 2024[38]. - There were no significant contingent liabilities as of December 31, 2024[41]. - The current ratio as of December 31, 2024, was approximately 5.07 times, up from 4.95 times on June 30, 2024[37]. - The debt-to-asset ratio as of December 31, 2024, was approximately 13.03%, a slight decrease from 13.49% on June 30, 2024[37]. Investment Activities - The group operates primarily in investment activities in Hong Kong and the People's Republic of China[7]. - The company plans to exit investments in the micro-lending industry due to concerns over declining interest rates and rising operational risks, while continuing to focus on investments in the bioenergy sector[31][32]. - The company sold 2,555,000 shares of Hengding Industrial, generating total proceeds of approximately HKD 149,000, resulting in a realized loss of approximately HKD 8,015,000 based on an investment cost of approximately HKD 8,164,000[29]. - The company holds a 30% equity interest in Hainan Keyi Huirui Bioenergy Technology Co., Ltd., with a cost of HKD 117,450,000[34]. - The company has a 30% stake in Henan Zhongxin Bioenergy Co., Ltd., with a fair value of HKD 22,109,000[34]. - The company is focusing on the bioethanol industry in China to maximize shareholder value[36]. - The company has invested in multiple joint ventures, including a 30% stake in Henan Tian Guan Energy Biochemical Technology Co., Ltd.[35]. - The company has a 30% interest in Jiangxi Huazhang Hancheng Guarantee Group Co., Ltd., with a cost of HKD 43,150,000[34]. - The company has a 30% stake in Xi'an Kairong Financial Services Co., Ltd., with a cost of HKD 18,724,000[34]. - The company is actively involved in the development and sales of clean energy products, including biofuels and chemical products[34]. - The company has a 30% equity interest in Tianjin Binlian Microfinance Co., Ltd., with a cost of HKD 12,271,000[34]. Financial Management and Governance - The company may need to secure additional equity or debt financing to support future capital plans[9]. - The company continues to monitor cash flow and assess future funding options based on market conditions[9]. - The financial statements are prepared in accordance with the Hong Kong Accounting Standards and reflect the group's ongoing business operations[10]. - The company emphasizes the importance of resource allocation and performance evaluation based on investment categories and related businesses[15]. - The group has applied new amendments to the Hong Kong Financial Reporting Standards, effective from July 1, 2024, which did not have a significant impact on the financial position[14]. - The group has adopted the corporate governance code and has complied with the relevant rules, with some deviations noted[46]. - The group recognized a reversal of impairment losses on other receivables amounting to HKD 3,677,000 for the six months ending December 31, 2024[22]. - The total profit from listed securities business during this period was HKD 3,356,000, with no dividend income recorded from listed investments for the six months ending December 31, 2024[28]. - The market value of listed securities as of December 31, 2024, was HKD 36,998,000, an increase from HKD 33,791,000 as of June 30, 2024[28]. - The group incurred a total loss of HKD 1,053,000 from unlisted investments during this period, a significant decline from a profit of HKD 53,431,000 in the same period last year[30]. - The fair value of unlisted investments decreased by 2.09% to HKD 51,244,000 as of December 31, 2024, down from HKD 52,339,000 as of June 30, 2024[30]. - The group’s net asset value as of December 31, 2024, was HKD 167,069,000, reflecting a slight increase from HKD 165,143,000 as of June 30, 2024[26]. - The total number of issued shares remained constant at approximately 10,971,634,030 shares as of December 31, 2024[42]. - The financing costs decreased from HKD 453,000 in 2023 to HKD 433,000 in 2024[18]. - The company aims to carefully assess and mitigate potential risks while striving to deliver greater returns to shareholders[36].

Financial Performance - The company reported a revenue of HKD 123 million for the six months ended December 31, 2023, compared to HKD 79 million in the same period last year, representing a 55.7% increase[5]. - The pre-tax profit for the period was HKD 68.325 million, a significant recovery from a loss of HKD 42.707 million in the previous year[5]. - The total comprehensive income for the period amounted to HKD 79.262 million, compared to a loss of HKD 64.148 million in the same period last year[5]. - Earnings per share for the period were HKD 0.62, compared to a loss per share of HKD 0.39 in the previous year[5]. - The total comprehensive income for the period ending December 31, 2023, was HKD 79,262,000, compared to HKD 572,789,000 for the same period in 2022, indicating a significant decrease[14]. - The company reported a loss of HKD 42,707,000 for the period ending December 31, 2022, which improved to a loss of HKD 77,778,000 for the period ending December 31, 2023[14]. - The company recorded a profit of HKD 68,325,000 for the six months ended December 31, 2023, compared to a profit of HKD 42,707,000 in the same period last year, representing a year-over-year increase of approximately 60.2%[166]. Assets and Liabilities - The company's net asset value increased to HKD 208.711 million as of December 31, 2023, up from HKD 129.449 million as of June 30, 2023[8]. - The total liabilities decreased to HKD 10.674 million from HKD 11.970 million, indicating improved financial stability[8]. - The total assets as of December 31, 2023, amounted to HKD 241,639,000, an increase from HKD 159,257,000 as of June 30, 2023[31]. - The company’s net current assets amounted to HKD 47,896,000 as of December 31, 2023[42]. - The current ratio as of December 31, 2023, was approximately 3.15 times, up from 1.93 times as of June 30, 2023[179]. - The debt-to-asset ratio as of December 31, 2023, was approximately 13.63%, down from 18.72% as of June 30, 2023[179]. Cash Flow and Financing - The company’s cash and cash equivalents stood at HKD 523 thousand, a slight decrease from HKD 606 thousand[8]. - Cash and cash equivalents at the end of the period were HKD 523,000, down from HKD 763,000 at the end of the previous period[42]. - The net cash generated from operating activities was HKD 725,000, a significant improvement from a net cash outflow of HKD 36,829,000 in the prior period[42]. - The company experienced a decrease in cash and cash equivalents due to net cash outflows from operating and investing activities totaling HKD 83,000[42]. - The company may need to secure additional equity or debt financing to support future capital plans, depending on external factors affecting cash flow[42]. - The company’s financing activities resulted in cash used of HKD 729,000, slightly higher than HKD 717,000 in the prior period[42]. Investments - The fair value of financial assets measured at fair value through profit or loss increased to HKD 142.470 million from HKD 83.448 million[8]. - The company’s financial assets at fair value through profit or loss included listed equity securities valued at HKD 15,221,000 and unlisted equity investments valued at HKD 83,448,000[17]. - The fair value of listed securities classified as financial assets at fair value through profit or loss was HKD 172,017,000 as of December 31, 2023, compared to HKD 98,669,000 on June 30, 2023, reflecting a 74.4% increase[66]. - The group’s investment in non-listed equity investments amounted to HKD 142,470,000 as of December 31, 2023, up from HKD 83,448,000 on June 30, 2023[66]. - The company has invested HKD 10,912,000 in Jiangxi Huazhang, with a fair value of HKD 10,912,000 as of December 31, 2023, unchanged from June 30, 2023[95]. - The company sold its entire stake in Mengzhou Houyuan for HKD 9,723,000, with a one-year credit period provided to the buyer[100]. - The company subscribed to 262,000,000 new shares of China Urban Infrastructure at HKD 0.50 per share, totaling HKD 131,000,000, representing approximately 8.4% of the total issued share capital as of December 31, 2023[118]. Strategic Focus and Future Outlook - The company is focusing on expanding its market presence and enhancing its investment strategies moving forward[5]. - The company plans to continue focusing on investments in the bioenergy sector while gradually exiting past investments in the microfinance industry to maximize shareholder value[171]. - The company plans to exit investments in the micro-lending industry due to concerns over declining interest rates and rising operational risks[193]. - The company’s management believes it has the ability to obtain financing to meet future capital plans, indicating a positive outlook for operational sustainability[22]. Employee and Management Costs - Employee costs, including director remuneration, decreased to HKD 2,295,000 from HKD 4,845,000 year-on-year[77]. - The investment management fee paid to CICC International Investment Management was HKD 68,000 for the six months ended December 31, 2023, down from HKD 89,000 in the same period of 2022[111]. - The group reported management fees of HKD 68,000 for the six months ending December 31, 2023, down from HKD 89,000 in the previous year[77]. Dividends and Share Options - The company did not recommend any interim dividend for the six months ending December 31, 2023, consistent with the previous year[35]. - The group has not declared any interim dividends for the period, consistent with the previous year[180]. - The company has a new share option plan approved by shareholders, effective for ten years until December 14, 2027[130]. - The company has not issued any share options under the new plan during the reporting period[132].